Increased circulating heat shock protein 70 ( XXXX ) levels in @entity6 : a pilot study.

@entity2175 @entity1 @entity6677 @entity4051 @entity6 @entity2285 @entity1878 @entity413
UNASSIGNED: Recent data indicate that serum @entity2285 ( @entity1878 ) levels are @entity2175 . However, there is no report in the literature on circulating @entity2285 levels in @entity6 . In this pilot study, we measured serum @entity2285 levels in 11 pregnant @entity1 with pregestational @entity6 , 38 @entity1 with @entity6677 , and 40 healthy pregnant @entity1 with ELISA. Plasma @entity413 levels, serum insulin concentrations, HbA1c values, and the Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) index were also determined. According to our results, serum @entity2285 concentrations were significantly higher in @entity1 with @entity6 than in healthy pregnant @entity1 . In addition, pregestational @entity6 @entity1 had significantly higher @entity2285 levels than those with @entity6677 . Furthermore, in the group of @entity1 with @entity6 , serum @entity2285 levels showed a significant positive correlation with @entity4051 c values. However, there was no other relationship between clinical features and metabolic parameters of the study subjects and their serum @entity2285 levels in either study group. In conclusion, we demonstrated for the first time in the literature that serum @entity2285 levels are increased and correlate with HbA1c values in @entity1 with @entity6 . Nevertheless, further studies are needed to determine whether circulating @entity2285 plays a causative role in the pathogenesis of @entity6677 or elevated serum @entity2285 levels are only consequences of the disease.
